e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Recent developments in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
A. Averyanov, A. Konoplyannikov, A. Chernyaev, V. Petrov, O. Kuzovlev, A. Bruchovetsky, O. Konoplyannikova, E. Agaeva, N. Kulagina (Moscow, Obninsk, Russian Federation)
Source:
Annual Congress 2011 - Recent developments in COPD
Session:
Recent developments in COPD
Session type:
Poster Discussion
Number:
418
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Averyanov, A. Konoplyannikov, A. Chernyaev, V. Petrov, O. Kuzovlev, A. Bruchovetsky, O. Konoplyannikova, E. Agaeva, N. Kulagina (Moscow, Obninsk, Russian Federation). Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats. Eur Respir J 2011; 38: Suppl. 55, 418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effects of adipose tissue-derived stromal/stem cells transplantation on elastase-induced pulmonary emphysema in rats
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice.
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Effect of intratracheal transplantation of bone marrow-derived endothelial progenitor cell on cigarette smoking-induced emphysema in mice
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017
Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
Altered proliferation of alveolar epithelial cells is involved in progressive elastase-induced emphysema
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021
Mesenchymal stem cells and conditioned medium in myofibroblast modulation and collagen production in vascular adventitia and parenchyma of experimental pulmonary fibrosis model
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 487s
Year: 2002
Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Influence of hypoxia-induced pulmonary hypertension on the domiciliation of infused mesenchymal stem cells in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 546s
Year: 2006
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept